Impact of Covid-19 in HSCT activity

Study type:

Study number:

8414(0)142

Type of treatment:

Allogeneic

Autologous

Diseases:

Complications: infectious

Short title:

Impact of Covid-19 in HSCT activity

Primary objective:

Investigate the impact of covid-19 on the transplant activity

Key inclusion criteria:

Autologous and Allogeneic transplanted patients from 2019-2021

Country:

All EBMT member countries

Principal investigator:

Rafael de la Camara, Per Ljungman, Zofia Szmit, Krzystztof Kalwak

EBMT Study coordinator:

Nina Knelange

Study coordinator email:

idwp.ebmt@lumc.nl

Reason for processing personal data:

Research and Development of new and improved transplant, cell therapy and immunosuppression procedures.

Categories of personal data collected:

Centers’ contact / Centers’ policies

Recipients who may access the data:

Leiden Study Unit

Statistical Unit

3rd-party processors of Personal Data on behalf of EBMT/Service provider:

No

Article 6 lawful basis for processing personal data:

Article 6.1 (e) - Public interest (Research) - Only for pandemia studies

Article 9 basis for processing special category data:

Article 9(2) (i) - Public interest in the area of public health (Safety reporting)

Is a Data Protection Impact Assessment required?:

DPIA performed for EBMT Registry (WP & NIS Studies)

Retention Schedule (if possible):

at least 5 years after the final report or first publication of study results